GlassScriptPhysician profile
Grant N Corning
NPI 1033259114
$1,610.71
in general payments reported to CMS, 2019-2025
11 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $27.44 · 2021: $268 · 2022: $264 · 2023: $357 · 2024: $259 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.93 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,007.16 | 2019-2025 | Clareon, Wavelight Refractive Suite, Simbrinza |
| Glaukos Corporation | $177.26 | 2021-2024 | Idose |
| The Cameron-Ehlen Group, INC. | $134.00 | 2019-2022 | |
| Rxsight INC | $105.77 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Sight Sciences, INC. | $58.35 | 2021-2022 | |
| Abbvie INC. | $49.28 | 2022-2024 | Alphagan P, Lumigan, Vuity |
| Sun Pharmaceutical Industries INC. | $18.29 | 2019 | |
| Bausch & Lomb Americas INC. | $18.27 | 2024 | Miebo, Xiidra |
| Katena Products, INC. (Dba Corza Medical) | $16.99 | 2019 | |
| Eyevance Pharmaceuticals LLC | $13.98 | 2021 | |
| Omeros Corporation | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Corning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.